Please find enclosed Annual report for the Financial year ended on 31st March, 2025 along with the Notice of the 38th AGM scheduled to be held on Saturday, 27th September, 2025 at 3.00 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pentokey Organy (India) Limited has filed its 38th Annual Report for the financial year ended 31st March 2025 along with the Notice of its 38th Annual General Meeting with BSE (Scrip Code: 524210). The AGM is scheduled for Saturday, 27th September 2025 at 3:00 PM, to be held via video conferencing, with remote e-voting open from 24th to 26th September 2025. Key financial results show total income fell sharply to Rs. 129.05 lakhs in FY24-25 from Rs. 484.77 lakhs in FY23-24, while net profit dropped to Rs. 24.55 lakhs from Rs. 87.25 lakhs. The Board has not recommended any dividend for the year to conserve resources. The company's main business remains trading of pharmaceutical products, with recent additions of fertilizers and pesticides trading. Ordinary business at the AGM includes adoption of financial statements and re-appointment of Mr. Purshottam Kejriwal, who retires by rotation.
Shareholders should note the sharp ~73% decline in revenue and ~72% fall in net profit compared to the previous year, along with the absence of any dividend. The AGM is routine regulatory compliance but the weak financial performance may be a concern for investors evaluating the stock.